None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.women with age 45-60 years 2.Amenorrhea more that 12 months 3.BMI less than equal to 35 kg/m2 4.presence of two or more menopausal symptoms 5.severity ranges from mild to moderate 6.participants willing to provide written informed consent and carry out studied procedures
Exclusion criteria
Exclusion criteria: 1.Abnormal vaginal bleeding 2.Severe blood pressure more than 190/120mmhg 3.Severe diabetes (Hba1c more than 10) 4.BMI more than equal to 35kg/m2 5.History of breast cancer and uterine cancer 6.Thromboembolic or Thrombophilia taking hormone or anti-peri menopausal medication 7.Liver disease 8.Thyroid Disorder 9.Depression 10.Use of steroids or any herbal medications for treatment of menopausal symptoms 11.Psychiatric drugs within last 2 months of treatment 12.Smoking and alcohol consumptions 13.Drug abuse 14.Subjects participated in any study before 180 days 15.Subjects using hormonal replacement therapy, non-hormonal replacement therapy, sedatives, antidepressants, anti-epileptic and subjects receiving alternative system of medicines 16.Patient unwilling to sign the informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of Black Cohosh in improving the menopausal symptoms in post menopausal women through menopausal rating scale in comparison with placeboTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of Black Cohosh in improving the quality of life in post menopausal women To assess the safety and adverse drug reaction (ADR) of Black Cohosh if any through World Health Organization - Uppsala Monitoring Centre (WHO-UMC) causality assessment scaleTimepoint: 1 year | — |
Countries
India
Contacts
SRM Medical college hospital and research center